Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy and Olfactory Network of Electro-acupuncture for Subjective Cognitive Decline

NCT: NCT06758154 · RECRUITING

NCT IDNCT06758154
StatusRECRUITING
Start Date2024-12-28
Completion2028-06-30
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (OTHER)
First posted
Last updated

Brief Summary

Subjective cognitive decline (SCD) is the early diagnosis and treatment window period of Alzheimer's disease (AD), and the identification of SCD individuals who will progress to AD (pSCD) is a research hotspot. Based on olfactory fMRI,previous studies have found that SCD individuals showed damaged entorhinal neural circuits. After follow-up, the incidence of pSCD increased by three times. But,the spatiotemporal characteristics of the entorhinal neural circuits and whether it has the value of individualized prediction and intervention target need to be further studied. Thus, based on multi-center ambispective cohort study at home and abroad, we will (1) build a new paradigm of synchronous fMRI-EEG olfactory task state Oddball experiment, jointly representational similarity analysis, extract spatiotemporal characteristics of neural circuits damage, and discover and verify that the entorhinal neural circuits are vulnerable brain regions; (2) establish the middle fusion model of vulnerable brain region combined with the methods of olfactory task-fMRI activation image generation, functional connectome gradient,etc.; Then, establish late fusion multi-omics multi-task model combined with the new methods of molecularomics such as ultra-deep total proteomics and metabonomics proposed by the research group to accurately identify pSCD; (3) carry out the precise intervention of image-guided "olfactory three-needle" acupuncture with the entorhinal neural circuits as the target. Through clinical RCT research and mouse model, the remodeling mechanism of vulnerable brain regions will be clarified.This project will provide the basis for early diagnosis and treatment of the AD risk population.

Frequently Asked Questions

What is Efficacy and Olfactory Network of Electro-acupuncture for Subjective Cognitive Decline?

Efficacy and Olfactory Network of Electro-acupuncture for Subjective Cognitive Decline is a clinical trial registered under NCT06758154. Current status: RECRUITING.

What is the status of NCT06758154?

The current status of NCT06758154 (Efficacy and Olfactory Network of Electro-acupuncture for Subjective Cognitive Decline) is: RECRUITING.

When did Efficacy and Olfactory Network of Electro-acupuncture for Subjective Cognitive Decline start?

Efficacy and Olfactory Network of Electro-acupuncture for Subjective Cognitive Decline started on 2024-12-28.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.